Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: Deubiquitinase USP18 mediates cell migration, apoptosis and ferroptosis in lung adenocarcinoma by depending on POU4F1/PRKAA2 axis

Fig. 7

Silencing USP18 reduced tumor growth in vivo by mediating POU4F1/PRKAA2 axis. (A) Establishment of xenograft model. (B-C) Tumor volume and weight of sh-NC, sh-USP18, sh-USP18 + POU4F1, sh-POU4F1, or sh-POU4F1 + PRKAA2 group. (D) Western blot was used to measure protein expression of PRKAA2 in tumor tissues. (E) PRKAA2 protein detection was carried out using IHC in tumor tissues. According to the positive cells (brown), IHC quantification analysis was completed by normalization of sh-NC group to 1. nP < 0.01, mP < 0.001

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us